Metabolomics Market Size, Share and Growth Analysis Report - Forecast Trends and Outlook (2026-2035)

Metabolomics Market Overview

The market is experiencing steady growth, driven by expanding applications in precision medicine, biomarker discovery, and drug development. Advancements in analytical technologies such as mass spectrometry and chromatography are enhancing data accuracy and throughput. Increasing research funding and integration with genomics and proteomics are further supporting metabolite profiling adoption across pharmaceutical, clinical, and academic research settings globally. The market reached a value of approximately USD 2.81 Billion in 2025.

Metabolomics Market Growth Drivers

Expanding Clinical Translation and Multiomics Infrastructure to Drive the Market Adoption

The rising pharmaceutical R&D expenditure and the growing adoption of multiomics workflows are accelerating the market expansion. Increasing outsourcing to specialized analytical service providers is further strengthening clinical research efficiency and scalability. For instance, in September 2025, Biognosys announced to launch metabolomics and lipidomics services supporting targeted metabolomics approaches for drug discovery and clinical research, strengthening multi-omics capabilities and enhancing translational research pipelines globally, while untargeted metabolomics enables comprehensive detection of metabolic alterations in complex biological systems.

Metabolomics Market Trends

Key trends shaping the market include the growing integration of metabolomics in oncology research, increasing focus on immunotherapy safety profiling, and expanding applications in CAR-T therapy studies.

Growing Integration of Metabolomics in Oncology and Immunotherapy Safety Profiling to Enhance the Market Landscape

The rising integration of metabolomics in oncology research and increasing focus on immunotherapy safety profiling are shaping advanced clinical applications. Expanding CAR-T therapy studies are driving a deeper understanding of metabolic mechanisms linked to treatment response and toxicity. For instance, in February 2026, Metabolon applied its metabolomics platform in CAR-T cell therapy research, identifying metabolic signatures associated with neurotoxicity and improving therapeutic safety frameworks, where metabolic flux analysis is enabling deeper insights into cellular metabolic reprogramming.

Metabolomics Market Segmentation

Metabolomics Market Share

Cancer Expected to Dominate the Market Segment by Indication

The market segmentation based on the indication include cancer, cardiovascular disorders, neurological disorders, inborn errors of metabolism, and other indications. Among these, cancer dominated the segment, accounting for over 44% of the market share in the historical period. The high share is attributed to increasing applications in early detection, treatment monitoring, and therapeutic research. The growing emphasis on biomarker discovery has significantly enhanced oncology research outcomes, supporting precision medicine approaches and driving sustained demand within the metabolomics market.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Metabolomics Market Analysis by Region

The regions included in the market are North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. Among these, North America is expected to lead the market, accounting for approximately 41% of the total market share in the historical period, supported by strong research infrastructure and significant funding. The region benefits from advanced analytical capabilities and early technology adoption. Increasing use of mass spectrometry across pharmaceutical and academic institutions is further strengthening market growth, enabling high-throughput analysis and improved metabolite identification accuracy.

Leading Players in the Metabolomics Market

Other key players in the market are Bio-Rad Laboratories, Inc., Metabolon, Inc., PerkinElmer Inc., Human Metabolome Technologies, Bioanalytical Systems, Inc., Danaher Corporation.

Key Questions Answered in the Metabolomics Market

• What was the metabolomics market value in 2025?
• What is the metabolomics market forecast outlook for 2026-2035?
• What major factors aid the demand for metabolomics market?
• How has the market performed so far, and how is it anticipated to perform in the coming years?
• What are the market’s major drivers, opportunities, and restraints?
• What are the major metabolomics market trends?
• Which products and services are expected to dominate the market segment?
• Which application is expected to dominate the market segment?
• Which indication is expected to dominate the market segment?
• Which end user is expected to dominate the market segment?
• Who are the key players in the metabolomics market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?